Clinical Trial Update: Determining the Impact of Penicillin in Latent RHD: The GOAL Trial [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating the impact of penicillin in latent rheumatic heart disease in children; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Diseases
• Latent Rheumatic Heart Disease
• Rheumatic Heart Disease

Drugs mentioned

• Penicillin (penicillin)

Snippet

Sponsor: Children's National Research Institute | Conditions: Rheumatic Heart Disease in Children, Latent Rheumatic Heart Disease | Phase 2 | Status: UNKNOWN